pro 2006 (treeage software)
90
Structured Review
treeage software
pro 2006
Pro 2006, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proc+univariate+normal+function/pro+2006+software/pmc06633882-140-9-11
Average 90 stars, based on 1 article reviews
Pro 2006, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proc+univariate+normal+function/pro+2006+software/pmc06633882-140-9-11
Average 90 stars, based on 1 article reviews
pro 2006 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Construct:Article Title: Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Article Snippet: 658 www.thelancet.com Vol 377 February 19, 201 Article Title: Cost-Effectiveness Analysis of Continuous-Flow Left Ventricular Assist Devices as Destination Therapy Article Snippet: Background—Continuous-flow left ventricular assist devices (LVADs) have become the dominant devices for mechanical circulatory support, but their cost-effectiveness is undetermined.. This study assessed the cost-effectiveness of continuous-flow devices for destination therapy versus optimal medical management in advanced heart failure and compared the results with previous estimates for pulsatile devices.. Methods and Results—A Markov model was developed to assess cost-effectiveness. Software:Article Title: Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Article Snippet: 658 www.thelancet.com Vol 377 February 19, 201 Article Title: Clinical efficacy and cost-effectiveness of HP-human FSH (Fostimon®) versus rFSH (Gonal-F®) in IVF-ICSI cycles: a meta-analysis. Article Snippet: Clinical efficacy of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH (rFSH) in IVF-ICSI cycles has long been compared, but no clear evidence of the superiority of a preparation over the other has been found.. Human gonadotropins have been often grouped together, but a different glycosylation may be present in each preparation, therefore influencing the specific bioactivity.. To exclude confounding factors, a meta-analysis and a costeffectiveness analysis were designed to compare effectiveness and cost-effectiveness of a specific highly purified human FSH (HP-hFSH) (Fostimon ) versus rFSH (Gonal-F ) in IVF/ICSI cycles. Article Title: Cost-Effectiveness Analysis of Continuous-Flow Left Ventricular Assist Devices as Destination Therapy Article Snippet: Background—Continuous-flow left ventricular assist devices (LVADs) have become the dominant devices for mechanical circulatory support, but their cost-effectiveness is undetermined.. This study assessed the cost-effectiveness of continuous-flow devices for destination therapy versus optimal medical management in advanced heart failure and compared the results with previous estimates for pulsatile devices.. Methods and Results—A Markov model was developed to assess cost-effectiveness. Article Title: Work-in-Progress Toward Incorporating Patients’ Preferences in Practice Guidelines for Imaging Aneurysmal Subarachnoid Hemorrhage Article Snippet: .. We are developing a decision analytic model in A-SAH patients using TreeAge Article Title: A Literature Review of Economic Evaluations for a Neglected Tropical Disease: Human African Trypanosomiasis (“Sleeping Sickness”) Article Snippet: Model Description (if applicable) , Spreadsheet model that simulates outcomes , Decision Tree with inclusion of relapses , Spreadsheet model that simulates outcomes based on the five strategies identified , Decision Tree , NA , Decision Tree. Complex decision tree model with separate arms for each stage of detection in the treatment algorithm specified. End diagnosis for positive tests is first or second stage of HAT. HAT-positive and HAT-negative populations examined to account Sens and Spe for TN, TP, FP, and FN. , Decision Tree. Melarsoprol and DMFO treatment arm options. Patients treated with melarsoprol have no complications or arsenic encephalopathy. Patients with no complications may relapse or be cured, while patients with an adverse event (AE) have a probability of survival prior to being cured or relapsing. Patients treated with DMFO have a probability of surviving treatment or dying. Survivors are cured or relapse. All relapse patients (DMFO and melarsoprol) have the possibility of being cured or proceed to death.. .. Software , Super-Calc 4 , Not mentioned , Microsoft Excel , TreeAge , Microsoft Access, Microsoft Excel, Epi Info 2002 , Data Pro 2004 (TreeAge) , Article Title: Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis. Article Snippet: Inserm ATIP-AVENIR ‘‘Modélisation, aide à la décision et coût-efficacité en maladies infectieuses’’, Lille/Paris, France; EA2694, Université Lille Nord de France, Lille, France; Service d’Hépato-gastroentérologie, Hôpital Huriez, CHRU de Lille, Lille, France; Service universitaire des Maladies infectieuses et du Voyageur, CH Dron, Tourcoing, France; Service d’Hépatologie et Transplantation, Hôpital Saint-Luc, CHUM, Montréal, Québec, Canada; Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany; University of Leipzig, Department of Gastroenterology and Rheumatology, Leipzig, Germany; Inserm U995, Université Lille Nord de France, Lille, France; Université Paris-Diderot, Paris, France; Service de Maladies infectieuses et tropicales, Hôpital Bichat Claude Bernard, Paris, France other:Article Title: When should women with placenta previa be delivered? A decision analysis Article Snippet: Univariate and multivariate sensitivity analyses were performed with TreeAge |